This case highlights a new pattern of RIPKI-related disease characterized by combined immunodeficiency, autoimmunity, and inflammation. It underscores the critical importance of early genetic diagnosis in pediatric patients with atypical presentations to avoid decades of morbidity and enable access to targeted, life-changing therapies.
Parentelli et al. (Sun,) studied this question.